Maravai LifeSciences Holdings, Inc.
MRVI
$3.08
-$0.21-6.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -130.77M | -121.00M | -192.52M | -162.71M | -144.85M |
| Total Depreciation and Amortization | 60.47M | 60.27M | 58.86M | 58.02M | 56.87M |
| Total Amortization of Deferred Charges | 1.65M | 1.91M | 2.26M | 2.62M | 2.90M |
| Total Other Non-Cash Items | 19.06M | 8.38M | 111.74M | 105.10M | 105.16M |
| Change in Net Operating Assets | -7.98M | 1.01M | -1.51M | 3.52M | -12.61M |
| Cash from Operations | -57.57M | -49.44M | -21.16M | 6.54M | 7.47M |
| Capital Expenditure | -13.15M | -16.88M | -22.55M | -29.23M | -29.66M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -18.99M | -18.99M | -18.99M | -18.63M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 734.00K | 1.65M | 1.28M | 4.66M | 5.34M |
| Cash from Investing | -31.41M | -34.22M | -40.26M | -43.20M | -24.32M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.44M | -234.51M | -234.47M | -234.43M | -234.39M |
| Issuance of Common Stock | 4.73M | 1.60M | 1.49M | 1.48M | 1.48M |
| Repurchase of Common Stock | -4.73M | -4.73M | -4.75M | -4.78M | -1.48M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -11.06M | -13.23M | -4.09M | -2.32M | -1.32M |
| Cash from Financing | -16.50M | -250.87M | -241.81M | -240.05M | -235.71M |
| Foreign Exchange rate Adjustments | -32.00K | -46.00K | -38.00K | 73.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -105.51M | -334.58M | -303.26M | -276.64M | -252.56M |